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Abstract
Background: The role of Aspergillus fumigatus mycotoxins in the colonization of the respiratory
tract by conidia has not been studied extensively, even though patients at risk from invasive
aspergillosis frequently exhibit respiratory epithelium damage. In a previous study, we found that
filtrates of A. fumigatus cultures can specifically alter the electrophysiological properties of human
nasal epithelial cells (HNEC) compared to those of non pathogenic moulds.
Results: We fractionated the organic phase of filtrate from 3-day old A. fumigatus cultures using
high-performance liquid chromatography. The different fractions were tested for their ability to
modify the electrophysiological properties of HNEC in an in vitro primary culture model.
The fraction collected between 20 and 30 min mimicked the effects of the whole filtrate, i.e.
decrease of transepithelial resistance and increase of potential differences, and contained
secondary metabolites such as helvolic acid, fumagillin, and verruculogen. Only verruculogen (10-8
M) had effects similar to the whole filtrate. We verified that verruculogen was produced by a
collection of 67 human, animal, plant and environmental A. fumigatus isolates. Using MS-MS analysis,
we found that verruculogen was associated with both mycelium and conidia extracts.
Conclusion:  Verruculogen is a secondary metabolite that modifies the electrophysiological
properties of HNEC. The role of these modifications in the colonization and invasion of the
respiratory epithelium by A. fumigatus on first contact with the epithelium remains to be
determined.
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Background
Aspergillus fumigatus is associated with many human
health conditions [1]. It is the most common cause of
invasive aspergillosis, an opportunistic infection whose
incidence increases in immunocompromised patients [2].
Aspergillosis is also prevalent in animals, such as dogs and
birds [3,4]. A. fumigatus is responsible for more human
and animal diseases than other moulds even though their
conidia are usually outnumbered by spores of other
mould species in inhaled air, suggesting that A. fumigatus
has special properties that enable it to colonize the lungs
of its hosts [5]. Most studies with A. fumigatus have
focused on the interactions of the fungus with alveolar
macrophages [6,7] or with cell line A549 from pneumo-
cytes [8,9]. However, the first tissue usually encountered
by the inhaled conidia is the airway epithelium, and it is
frequently damaged in patients at risk for invasive
aspergillosis [10]. We previously studied the interactions
between A. fumigatus and the respiratory epithelium using
human nasal epithelium cell (HNEC) cultures [11,12].
After one week of culture, the HNEC are organized in a
pseudostratified epithelium with mucus and ciliated cells,
very similar to the in vivo airway epithelium [12].
We found that a filtrate from A. fumigatus cultures has spe-
cific electrophysiological effects on HNEC compared with
one from fungi not responsible for invasive infection [11].
Effects included a decrease in transepithelial electrical
resistance and polarization of the epithelium. These
changes to the epithelium properties could play a role in
the ability of A. fumigatus to colonize the respiratory tract.
In the present study, in order to identify which com-
pounds were responsible for these changes, we used high-
performance liquid chromatography with diode-array
detection (HPLC-DAD) to fractionate the filtrate of A.
fumigatus culture. Thus, we identified verruculogen as the
toxin responsible for the toxic effects observed in the epi-
thelial cell model. To determine whether verruculogen
was associated with conidia upon its first contact with epi-
thelial cells, the presence of verruculogen was specifically
monitored in conidial extracts by mass spectrometry anal-
ysis. Moreover, since every isolate of A. fumigatus is poten-
tially responsible for invasive aspergillosis (as previously
shown using polymorphic microsatellite markers
[13,14]), the ability of every isolate to produce verruculo-
gen was a prerequisite for involving verruculogen as a
pathogenic factor. The production of verruculogen was
therefore verified in a collection of 67 human, animal,
plant and environmental A. fumigatus isolates.
Results
We first fractionated the metabolites and analyzed the
organic phase profile obtained with 25°C fungi cultures,
to obtain enough metabolites to be seen in HPLC analy-
sis. For 25°C fungi cultures, we detected and identified
fumigaclavine A and C, fumitremorgin C, verruculogen,
and fumagillin by comparison with authentic standards
(Figure 1). For 37°C culture, other metabolites were iden-
tified on the basis of their UV spectrum: fumigaclavine A,
gliotoxin, fumiquinazoline F, fumitremorgin C, fumagil-
lin, and helvolic acid. When testing the different HPLC
fractions and commercial products, the results obtained
after 30 min or 3 hours of exposure were similar. There-
fore, only the 30 min results were retained.
At 37°C, only the 20–30 min fraction 3 (F 3) increased
the Vt (Figure 2). As this fraction was known to contain
the secondary metabolites helvolic acid, fumagillin and
verruculogen, the effects of different concentrations of
these commercially available compounds were tested.
Helvolic acid had no significant effect (data not shown).
The effects of fumagillin are summarized in Figure 3 and
were opposite to the effects of F3. Only verruculogen
showed effects similar to those of F3. In Figure 4, the
effects of different concentrations of verruculogen are pre-
sented, ranging from 10-4 to 10-9 M. The effects on Rt and
Vt were slightly dissociated, as 10-4 and 10-6 M verruculo-
gen decreased Rt and increased Vt, whereas 10-7 and 10-8
M verruculogen only increased Vt with no significant
effect on Rt.
To verify that verruculogen was responsible for the effects
of fraction 3, F3 was further fractionated into five two-
minute fractions (F'1-5). In these HPLC conditions, ver-
ruculogen was recovered in F'3 (24–26 min) while hel-
volic acid and fumagillin were eluted together in F'5 (28–
30 min). Among the five tested fractions, only F'3 dis-
played results similar to those of F3. Since verruculogen is
produced in greater amounts at 25°C than at 37°C [15],
we performed similar experiments with the organic phase
obtained at 25°C to look for a concentration effect. For
25°C culture, F'3 revealed an increase in Vt and a decrease
in Rt within the same range as 10-6 M standard verruculo-
gen, whereas the effects observed with F'3 of 37°C culture
were similar to those obtained with lower concentrations
of verruculogen (data not shown).
Fraction F'3 was analyzed by mass spectrometry and ver-
ruculogen was identified on the basis of electron ioniza-
tion MS and UV spectral analysis, after comparison with a
reference standard. In the analysis of fraction F'3, the mass
spectrum of verruculogen showed two major ions at m/z
494 and 534, corresponding to loss of water and sodium
adduct, respectively (Figure 5). The collision-induced dis-
sociation MS-MS spectrum of the 494 ion led to fragment
at m/z 410, identical to that of authentic verruculogen
[16].
The amounts of fumagillin and verruculogen were esti-
mated by HPLC-DAD using standard curves. F'3 con-BMC Microbiology 2007, 7:5 http://www.biomedcentral.com/1471-2180/7/5
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tained 4.15 µg of fumagillin for 37°C culture and 3.96 µg
for 25°C culture. Therefore, the concentration of fumagil-
lin in culture filtrate used to challenge the HNEC was 0.36
10-6 M, more than 300 times lower than the lowest con-
centration, 1.1 10-4 M, of purified fumagillin resulting in
a significant effect (Figure 3), thus definitively excluding
fumagillin as the toxin involved in our observations. For
verruculogen, F'3 of 37°C culture contained less than 80
ng of verruculogen and Fraction F'3 of 25°C culture con-
tained 2.1 µg of verruculogen. The concentrations
obtained after resolubilization in DMSO and dilution to
challenge HNEC corresponded to 0.6 10-6 M for 25°C cul-
ture and 1.4 10-8 M of verruculogen for 37°C culture.
Compared with the results obtained with the serial dilu-
tions of standard verruculogen (Figure 4), fraction F'3 of
25°C culture showed an increase in Vt and Rt, as did the
10-6 M concentration, whereas F'3 of 37°C culture pre-
sented a decrease in Vt in the same way as the 10-8 concen-
tration.
Verruculogen was detected by HPLC-DAD in the 67 A.
fumigatus hyphal and conidial extracts tested, from 0.13 to
17.2 µg/g of wheat. One extract of conidial fractions was
also analyzed by mass spectrometry to verify the presence
of verruculogen. In positive mode, verruculogen (molecu-
lar weight: 511 g/mol) was detected in conidial extract.
The presence of verruculogen was confirmed after 14.8
min of elution, at which time its mass spectrum corre-
sponded to that of standard verruculogen. In these
extracts, seven other compounds were also specifically
detected (emodin, gliotoxin, fumigaclavine C and four
compounds of the tremorgen family, namely tryprostatin
HPLC – Chromatogram at 270 nm of A. fumigatus IP 2279-94, growth at 25°C in MEM and UV spectra of metabolites detected  in this culture: fumigaclavine A [A], gliotoxin [B], fumigaclavine C [C], fumitremorgin C [D], verruculogen [E], and fumagillin [F] Figure 1
HPLC – Chromatogram at 270 nm of A. fumigatus IP 2279-94, growth at 25°C in MEM and UV spectra of metabolites detected 
in this culture: fumigaclavine A [A], gliotoxin [B], fumigaclavine C [C], fumitremorgin C [D], verruculogen [E], and fumagillin 
[F]. The first fractionation was performed as follows: four 10-minute fractions (F1-4) and one 6-minute fraction (F5). F3 frac-
tion was secondarily split into two-minute fractions (F'1-5). Pink line: gradient line.
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A, TR2, fumitremorgin C, and dihydroxy-fumitremorgin
C).
Discussion
The production of toxins by A. fumigatus may help the
fungus to colonize and invade the respiratory epithelium
by modifying the natural clearance of the respiratory tract.
Previous research has shown that A. fumigatus culture fil-
trate modifies the transepithelial resistance (Rt) and tran-
sepithelial potential differences (Vt) of HNEC, an in vitro
model of the air-liquid interface of airway epithelium
[11]. The aim of this study was to use HPLC and MS-MS
to identify which toxins produced by A. fumigatus are
responsible for these modifications. Our data suggest that
verruculogen, which has never been implicated in inva-
sive aspergillosis, is one of the probable candidates.
The fact that A. fumigatus produces a number of biologi-
cally active substances that slow ciliary beating, damage
epithelium, and that may affect colonization of the air-
ways has already been reported using culture explants
[17]. Among these substances, such toxins as gliotoxin,
fumagillin, and helvolic acid have been implicated in the
pathogenesis of aspergillosis [18]. Our results did not sug-
gest the involvement of any of these toxins in the effects
observed on our in vitro model of respiratory epithelium.
The HPLC fraction known to contain gliotoxin had no
detectable effect, suggesting that the concentration of gli-
otoxin in the fungal filtrate was too low to play a role in
the observed effects. For fumagillin, the effects were differ-
ent from those of the whole A. fumigatus culture filtrate
and were only observed with concentrations above those
found in the culture filtrate. With the helvolic acid, we did
not observe any effects at the tested concentrations based
on the residual extract HPLC analysis. Therefore, we con-
cluded that none of these metabolites were responsible
for the electrophysiological modifications of HNEC. Nev-
ertheless, their role, especially in association, cannot be
completely ruled out. For instance, gliotoxin is known to
be produced by A. fumigatus during the exponential
growth phase at 37°C [19]. Therefore, the role of gliotoxin
may be minimal in the first days of colonization, after the
seeding of airway epithelium, but become crucial at a later
stage of infection. Gliotoxin has been detected in patients
suffering from aspergillosis [20] and in bovine udder
infected with A. fumigatus [21].
Our results strongly suggest that verruculogen is one of the
candidate toxins, if not the sole toxin, responsible for the
changes of HNEC observed with culture filtrate. Our argu-
ments are based on the fact that: (i) only the fraction con-
taining verruculogen modified Vt and Rt, (ii) the
concentration of verruculogen in the organic extract corre-
sponds to the concentration obtained from the standard
curve produced with pure commercial toxin, (iii) the tem-
perature of 25°C, which fosters the production of verruc-
ulogen by A. fumigatus, led to increased effects, and that
(iv) heating the filtrate at 100°C for 10 min did not mod-
ify the effects on HNEC [11] and is known not to modify
the structure of verruculogen (this was verified by HPLC
analysis; not shown).
Verruculogen is one of the tremorgenic mycotoxins pro-
duced by fungi belonging to the genera Penicillium and
Aspergillus  that elicit intermittent or sustained tremors
(staggers syndromes) in vertebrate animals [22,23]. The
clinical symptoms typically observed during mycotoxin
poisoning include diminished activity and immobility,
Effect of the five fractions obtained by HPLC-DAD of the  organic phase of the 37°C A. fumigatus culture filtrate at 1/2 h Figure 2
Effect of the five fractions obtained by HPLC-DAD of the 
organic phase of the 37°C A. fumigatus culture filtrate at 1/2 
h. Only F3 (20–30 min) showed a significant increase in tran-
sepithelial potential differences (Vt) and a decrease, albeit not 
significant, in transepithelial resistance (Rt).  *: significant dif-
ference compared with HNEC culture medium with DMSO 
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Effect of serial dilutions of standard fumagillin at 1/2 h Figure 3
Effect of serial dilutions of standard fumagillin at 1/2 h. The first significant effects observed, i.e. a decrease in transepithelial 
potential differences (Vt) and an increase in transepithelial resistance (Rt), were the opposite of those observed with the whole 
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Effect of serial dilutions of standard verruculogen at 1/2 h Figure 4
Effect of serial dilutions of standard verruculogen at 1/2 h. The first significant effects observed, i.e. an increase of transepithelial 
potential differences (Vt) and a decrease of transepithelial resistance (Rt), were similar to those observed with the whole 









































* *BMC Microbiology 2007, 7:5 http://www.biomedcentral.com/1471-2180/7/5
Page 7 of 11
(page number not for citation purposes)
Positive mode electrospray ionization MS analysis of the F'3 fraction Figure 5
Positive mode electrospray ionization MS analysis of the F'3 fraction. Despite the fact that the molecular ion at m/z 512 (M+ 
H)+ is not observed, the presence of ions at both m/z 494 (M- H2O)+ and m/z 534 (M + Na)+ enables this compound to be iden-
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followed by hyper-excitability, convulsions, muscle
tremor, ataxia, and tetanic seizures. However, death rarely
occurs and these symptoms are reversible if the animals
are removed from the toxic-feed source. The concentra-
tions detected in our A. fumigatus filtrates are considerably
lower than those reported when clinical symptoms of poi-
soning are observed in ruminants. No data are yet availa-
ble in relation to the concentration dependence of human
susceptibility. Verruculogen is known as an inhibitor of
K+ channels in synaptic in vitro models [23,24]. Since ver-
ruculogen has never been tested on HNEC, additional
research is needed to identify the prime action site on
HNEC. The action of verruculogen could be extended to
other targets such as DNA [25].
In order to include verruculogen as one of the virulence
factors of A. fumigatus, toxin should be present in all the
A. fumigatus isolates. No specific isolates have been shown
to be more pathogenic than others in humans [13,26,27]
or birds [3]. According to some authors, 40% to 91% of
the A. fumigatus isolates produce verruculogen [28,29].
The production of mycotoxins at an easily detectable level
is very dependent on culture medium and temperature.
For instance, verruculogen is produced in larger amounts
at 25°C than at 37°C [15]. Generally, greater amounts of
mycotoxins are detected in grain cultures than in standard
liquid cultures. Moreover, the production of toxins on
grains is more physiological for a mould than the produc-
tion of toxins in microbiological medium such as PDA or
Sabouraud medium. Using autoclaved grains as a culture
support, we were able to show that 67 different A. fumiga-
tus isolates are able to produce verruculogen. As we do not
observe direct cell lysis with low concentrations of verruc-
ulogen, further studies are required to test whether verruc-
ulogen is a virulent factor in the strictest sense, i.e. a
component that damages the host cells [30]. However, a
verruculogen-deficient mutant strain would probably not
be informative, since the pathogenicity of A. fumigatus is
multifactorial. Indeed, all experiments performed to
prove the role of a specific molecule in the virulence of A.
fumigatus have failed, with the exception of melanin-defi-
cient mutants [5] and mutants deficient in the
siderophore biosynthesis [31,32].
To take on a primary role in the colonization and/or inva-
sion of airway epithelium, verruculogen not only has to
be present in every A. fumigatus isolate, but also has to be
associated with conidia and delivered directly onto the
epithelial cells. The presence of verruculogen at the cellu-
lar level could alter pulmonary clearance and thereby
increase colonization and the risk of invasive aspergillo-
sis. Some authors have found verruculogen in very few
conidial extracts [33]. Using MS/MS, we found that ver-
ruculogen is associated with conidia (although contami-
nation with residual hyphae is always possible).
Therefore, verruculogen can act on its first contact with
epithelial cells. Furthermore, the detection of verruculo-
gen in conidial extracts presents opportunities for investi-
gation into the potential role of inhalation in the intake of
mycotoxins by humans. The recent detection of abundant
respirable ergot alkaloids associated with A. fumigatus
conidia raises the possibility of the respiratory epithelium
as an alternative to the digestive route for the intake of
these mycotoxins [34].
Conclusion
The HPLC-MS and HPLC-MSn analysis techniques used in
this study according to recent FDA recommendations [35]
confirm the existence of verruculogen and other mycotox-
ins associated with conidia. The identification of the tox-
ins secreted by A. fumigatus and their role in humans is a
long-running enterprise involving microbiology, chemis-
try, and mammalian cell cultures. For the first time, we are
including verruculogen as a toxin with deleterious effects
on respiratory epithelial cells. Whatever the exact role of
verruculogen, it is not the only factor involved in the prev-
alence of A. fumigatus in invasive disease compared with
other moulds. Verruculogen is, for instance, secreted by
Penicillium verruculosum, which has never been implicated
in invasive disease. Verruculogen may act first, leading to
settlement of the fungus and subsequently allowing other
toxins to be produced if the fungus grows. Additionally,
verruculogen might be synergistic or antagonistic with
other molecules or proteases produced by A. fumigatus.
Methods
HNEC primary cultures
The HNEC culture conditions were adapted from a culture
model originally developed with human tracheobron-
chial cells [36,37]. Nasal polyps were sampled in patients
with nasal polyposis during ethmoidectomy. HNEC cul-
tures were prepared as previously described [11]. In brief,
each polyp was placed overnight at 4°C in PBS-antibiotics
(100 U/ml penicillin, 100 mg/ml streptomycin, 2.5 µg/ml
amphotericin B and 100 mg/ml gentamicin) solution
containing 0.1% pronase (Sigma-Aldrich, L'Isle d'Abbeau
Chesnes, France). After rinsing, the cells were dissociated
in a 0.25% trypsin solution (Invitrogen, Cergy Pontoise,
France) and 106 cells were plated in 12-mm insert wells
(Corning BV, Schiphol-Rijk, The Netherlands) with
microporous membranes coated with type IV collagen
(Sigma-Aldrich) and incubated at 37°C in 5% CO2. After
24 h, the culture medium was removed from the apical
compartment to obtain an air-liquid interface. The basal
compartment was filled with 1 ml of the HNEC culture
medium, consisting of DMEM/F12 with 2% Ultroser G
(Sigma-Aldrich) with antibiotics (100 U/ml penicillin,
100 mg/ml streptomycin, and 100 mg/ml gentamicin).
The HNEC culture medium was changed daily and the
electrophysiological properties of the HNEC were checkedBMC Microbiology 2007, 7:5 http://www.biomedcentral.com/1471-2180/7/5
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twice weekly using a microvoltmeter with concentric elec-
trodes (EVOM® World Precision Instruments, Stevenage,
UK).
Fungal strain culture conditions and mycelium mycotoxin 
extraction
We used Aspergillus fumigatus IP 2279-94, originally iso-
lated from a patient with invasive aspergillosis. The strain
was cultured on Potato Dextrose Agar (PDA) medium
(Sigma-Aldrich) at 37°C for 7 days in the dark. Conidia
were collected by gently scraping with spatula and rinsing
the PDA Petri dish surface with tryptone salt solution
(tryptone 0.1%, 0.8% sodium chloride, 0.1% Tween 80).
The suspension was filtered through sterile compresses to
remove hyphae. Two hundred and fifty µl of conidial sus-
pensions (2.105 conidia/ml) were used to inoculate three
500 ml Erlenmeyer flasks each containing 100 ml mini-
mal Eagle's medium (Sigma-Aldrich) supplemented with
5% sterile fetal calf serum, and flasks were then placed in
a shaking incubator at 180 rpm for 3 days at 25°C and
37°C, as previously described [38]. After filtration of col-
lected medium through Whatman N°1, the pH of the fil-
trate was checked and the fungal cultures were extracted
with 70 ml chloroform for 4 days at room temperature.
The organic phase was evaporated under vacuum at 50°C
using a rotary evaporator. The residue was taken up in 200
µl methanol; this suspension was then filtered through a
disposable filter with 0.45 µm pores before injection (20
µl) into the chromatograph apparatus.
Chemicals
Verruculogen, fumagillin, and helvolic acid from Sigma-
Aldrich were used without further purification (purities
higher than 90%). The sources of the other secondary
metabolites used as authentic standards were: P.M. Scott,
Health Canada, Ottawa, Canada (fumigaclavine A), J.W.
Dorner, National Peanut Research Laboratory, ARS-
USDA, Dawson, USA (fumigaclavine C), C. Avendano.
Universidad Complutense, Madrid, Spain (fumiquinazo-
line F), P.G. Mantle, Imperial College, London, UK (TR2)
and H. Osada, RIKEN Institute, Wako, Japan (Tryprostatin
A). Fumitremorgin C was purchased from Alexis Bio-
chemicals.
Fractionation of culture filtrates by HPLC and 
identification of secondary metabolites
The residual extract was fractionated and fungal metabo-
lites were analyzed by HPLC-DAD using a 150 mm × 4
mm Zorbax ODS 5 µm C18 column (Bischoff, Leonberg,
Germany) in an HPLC chromatograph apparatus (Kon-
tron, Milan, Italy). HPLC analysis was performed based
on a modified Frisvad chromatographic method [39],
with a flow rate of 2 ml/min and a linear elution gradient
of acetonitrile (solvent B) in 0.2% acetic acid (solvent A).
Analysis started with 10% of solvent B, which was
increased to 50% after 30 min, and then to 90% four min
later, maintained at 90% for a further 4 min, then
decreased over 7 min to 10%, and finally maintained at
10% over 1 min. Compounds were identified by compar-
ison with mycotoxin standards analyzed in the same man-
ner. The first fractionation was performed as follows: four
10-minute fractions (F1-4) and one 6-minute fraction
(F5) were collected after DAD detection. Fractions were
evaporated and taken up in 25 µl DMSO. Ten µl of the
DMSO-solubilized HPLC fractions were diluted in 90 µl
of HNEC medium, 15 µl of this solution were diluted in
1.5 ml of HNEC medium, and 750 µl of this final solution
were used to immerse one HNEC well. After an initial bio-
logical activity screening, the positive fraction was split in
the same way into two-minute fractions (F'1-5). Fractions
were evaporated and taken up as described above.
Biological activity of the fractions on HNEC
All experiments were performed on 14-day HNEC cul-
tures when cell differentiation was established and stable.
All tests were performed in duplicate and each experiment
was repeated at least three times with different HNEC cul-
tures. Interactions between HNEC and fungi were evalu-
ated using bioelectrical properties of HNEC cultures, i.e.
transepithelial resistances (Rt) and potential differences
(Vt), which measure intercellular junction permeability
and trans-cellular ionic transport, respectively [40]. For
14-day cultures, the usual range of Rt and Vt is 600 to 800
ohms/cm2 and -20 to -40 mV, respectively. The day before
the assay (referred to as T0), the HNEC inserts were
immersed in 750 µl of HNEC culture medium. After 30
min to balance electrodes, the Rt and Vt were recorded.
After the first measurement, the culture medium was
removed from the apical side to recover the air-liquid
interface. Twenty-four hours later, 750 µl of the solution
containing the tested product were added to the apical
side of HNEC cultures and the electrophysiological values
were measured at 30 minutes and 3 hours. For a given
well, the results were expressed as a percentage variation
from the T0 measurements. Calculations were performed
using the mean +/- SEM obtained from at least three dif-
ferent cultures.
Ability of different A. fumigatus isolates to produce 
verruculogen
Sixty-seven A. fumigatus strains of the Pharmacology Tox-
icology Laboratory New Collection (NCPT, INRA Tou-
louse, France) were examined for their ability to produce
verruculogen. These strains were selected from various
human, animal, plant and environmental sources and
geographical regions. Verruculogen production by A.
fumigatus  strains was measured in autoclaved grains of
Ardente, a variety of durum wheat. One hundred grams of
wheat grains were moistened with 100 ml of sterile dis-
tilled water for 4 days at 4°C, before sterilization. TwentyBMC Microbiology 2007, 7:5 http://www.biomedcentral.com/1471-2180/7/5
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grams of grain were placed in a 140 mm diameter Petri
dish. Each dish was inoculated with 250 µl containing 2 ×
105 conidia and incubated at 25°C for 13 days. The fungal
cultures were extracted with 100 ml chloroform as
described above.
Mycotoxin extraction from conidia
For detection of mycotoxins associated with conidia, and
after having demonstrated that production of verruculo-
gen was effective with every A. fumigatus isolate, we pur-
sued experimentation with the NCPT strain 13, which has
been used for numerous experiments with mycotoxin pro-
duction (also available under number NRRL 35693 at the
Northern Region Research Laboratory, USDA-ARS, Peoria,
Ill, USA). Large amounts of A. fumigatus conidia of the
NCPT strain 13 were produced on Czapek Yeast Extract
Agar (CYA) medium for 14 days at 37°C. Conidia were
collected by inverting CYA Petri dishes over a collecting
flask. Conidia (10 mg) were gently mixed for 1 min in 2
ml of 0.9% sodium chloride solution containing 0.1%
Tween 80. After harvesting, the suspension was filtered
through a porosity 2 filter-funnel to remove hyphae and
extracted for 4 days by shaking in 10 ml of chloroform at
room temperature. The extract was evaporated under vac-
uum at 50°C on a rotary evaporator. The crude extract was
taken up in 500 µl of methanol, and this solution was fil-
tered through a 0.45 µm Teflon filter before liquid chro-
matography and mass spectrometry analysis.
HPLC-MS and MS-MS analysis
The LC-MS-MS instrument used was an LCQ DUO Ion
Trap from Thermo-Finnigan. The LC separation was done
on a 150 × 2.1 mm C18 Kromasil column (Interchim,
Montluçon, France) using a 30-minute linear gradient of
10% to 90% acetonitrile in the presence or absence of
0.1% formic acid (presence for positive ionization mode).
Electrospray ionization (ESI) was performed at 4.5 kV and
the capillary temperature was set to 250°C using a gas
flow of 70 ml/min and an auxiliary gas flow of 20 ml/min.
MS and MS-MS tuning were performed on 5 µM authentic
verruculogen and the MS-MS collision was set at 48%.
Whole mycelium and conidial extracts were analyzed in
negative and positive ESI mode in full scan and MS-MS
mode with an m/z range of 80 to 700. The mass spectra of
the positive fraction and verruculogen standard were
obtained by infusion in positive ESI mode.
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